Nonobese Diabetic (NOD) Mice Lack a Protective B-Cell Response against the “Nonlethal”Plasmodium yoelii17XNL Malaria Protozoan
Author(s) -
Mirian Mendoza,
Luis Pow Sang,
Qi Qiu,
Sofía Casares,
TeodorD. Brumeanu
Publication year - 2016
Publication title -
malaria research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.726
H-Index - 15
eISSN - 2090-8075
pISSN - 2044-4362
DOI - 10.1155/2016/6132734
Subject(s) - plasmodium yoelii , malaria , nod , medicine , plasmodium falciparum , immunology , diabetes mellitus , biology , endocrinology , parasitemia
Background . Plasmodium yoelii 17XNL is a nonlethal malaria strain in mice of different genetic backgrounds including the C57BL/6 mice (I-A b /I-E null ) used in this study as a control strain. We have compared the trends of blood stage infection with the nonlethal murine strain of P. yoelii 17XNL malaria protozoan in immunocompetent Nonobese Diabetic (NOD) mice prone to type 1 diabetes (T1D) and C57BL/6 mice (control mice) that are not prone to T1D and self -cure the P. yoelii 17XNL infection. Prediabetic NOD mice could not mount a protective antibody response to the P. yoelii 17XNL-infected red blood cells (iRBCs), and they all succumbed shortly after infection. Our data suggest that the lack of anti- P. yoelii 17XNL-iRBCs protective antibodies in NOD mice is a result of parasite-induced, Foxp3 + T regulatory (Treg) cells able to suppress the parasite-specific antibody secretion. Conclusions . The NOD mouse model may help in identifying new mechanisms of B-cell evasion by malaria parasites. It may also serve as a more accurate tool for testing antimalaria therapeutics due to the lack of interference with a preexistent self -curing mechanism present in other mouse strains.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom